Drugmaker’s Xevudy fails to tackle most prevalent variants of coronavirus, say US regulators
GSK
Kate Ferry to replace Julie Brown who heads to GSK
Drug giant rang up worldwide sales of more than £29 billion last year. Its refusal to contribute a cent to State’s redress scheme is inexcusable
Questions remain about hospitalisation and side effects but drugmaker stays step ahead of British group GSK which faces similar panel
In the News podcast with Bernice Harrison
Clinical trials carried out between 1934 and 1973 centred on childhood vaccines and infant milk products
O’Gorman urged drug firm to accept corporate responsibility for way tests were carried out on mother-and-baby home children
UK drugmaker counting on several new vaccines, including one against RSV, to power growth in 2023
Chief commercial officer Luke Miels looking at targets, especially in cancer therapies, worth up to $2.5bn
Pharmaceutical companies hunt for new revenue streams as pandemic becomes endemic
Rump business will focus solely on vaccines and prescription medications
Sanofi says trials point to potential of its vaccine booster candidate against main variants of concern
YOU MAY ALSO LIKE...
Crosswords & puzzles to keep you challenged and entertained
Explore how the historic deal helped bring about peace in Northern Ireland
Start The Search For Your Next Job
Inquests into the nightclub fire that led to the deaths of 48 people
A project examining attitudes about the future of Ireland
Weddings, Births, Deaths and other family notices